Profilo
Ruth B.
Kunath served a Director of Dendreon Corp.
from December 1999 to June 4, 2008.
She was Biotechnology Portfolio Manager of Vulcan, Inc. from 1991 to November 2003 and worked at Seattle Capital Management.
Ms. Kunath was Senior Portfolio Manager for the Healthcare Sector of Bank of America Capital Management.
She received a BA degree from DePauw University and is a Chartered Financial Analyst.
Precedenti posizioni note di Ruth B. Kunath
| Società | Posizione | Fine |
|---|---|---|
| DENDREON CORPORATION | Direttore/Membro del Consiglio | 04/06/2008 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Ruth B. Kunath
